Vintage Sulfazine EC recall (correction)
Executive Summary
A recall of Sulfazine EC (sulfasalazine delayed release) listed in FDA's April 6 Enforcement Report incorrectly describes it as occurring in 2005 (1"The Pink Sheet" April 11, 2005, p. 33). "On March 4, 2004 Vintage Pharmaceuticals Inc. sent a letter to Qualitest Pharmaceuticals recalling these two lots," Vintage said. "On March 8, 2004 Qualitest Pharmaceuticals sent a letter to its wholesale customers recalling these two lots. Vintage submitted a closeout package for the recall to FDA on April 7, 2005"...
You may also be interested in...
Chart: FDA Recalls & Court Actions
FDA Recalls & Court Actions
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.